Invention Grant
- Patent Title: Selective PYY compounds and uses thereof
-
Application No.: US15036201Application Date: 2014-11-13
-
Publication No.: US10246497B2Publication Date: 2019-04-02
- Inventor: Soeren Oestergaard , Kilian Waldemar Conde Frieboes , Birgit Wieczorek , Jens Kaalby Thomsen , Birgitte Schjellerup Wulff , Carsten Jessen
- Applicant: Novo Nordisk A/S
- Applicant Address: DK Bagsvaerd
- Assignee: Novo Nordisk A/S
- Current Assignee: Novo Nordisk A/S
- Current Assignee Address: DK Bagsvaerd
- Agent Rosemarie R. Wilk-Orescan
- Priority: EP13193082 20131115; EP14176725 20141107
- International Application: PCT/EP2014/074476 WO 20141113
- International Announcement: WO2015/071355 WO 20150521
- Main IPC: C07K14/47
- IPC: C07K14/47 ; A61K38/17 ; A61K45/06 ; C07K14/575 ; A61K38/22 ; A61K38/00

Abstract:
The invention relates to PYY compounds having the amino acid in the position corresponding to position 30 of hPYY(1-36) substituted with tryptophan and derivatives thereof with a modifying group attached to the position corresponding to position 7 of hPYY(1-36). The compounds of the invention are selective Y2 receptor agonists. The invention also relates to pharmaceutical compositions comprising such PYY compounds and pharmaceutically acceptable excipients, as well as the medical use of the PYY compounds.
Public/Granted literature
- US20160289283A1 SELECTIVE PYY COMPOUNDS AND USES THEREOF Public/Granted day:2016-10-06
Information query